company background image
CHE logo

Chemed NYSE:CHE Stock Report

Last Price

US$523.16

Market Cap

US$7.8b

7D

-4.4%

1Y

-11.8%

Updated

20 Dec, 2024

Data

Company Financials +

Chemed Corporation

NYSE:CHE Stock Report

Market Cap: US$7.8b

CHE Stock Overview

Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. More details

CHE fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance6/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 30.8% below our estimate of its fair value

Earnings are forecast to grow 8.76% per year

Earnings grew by 23.4% over the past year

Analysts in good agreement that stock price will rise by 26.9%

Risk Analysis

Significant insider selling over the past 3 months


My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
Analyst Price Target
Consensus Narrative from 3 Analysts

Integration Of Covenant Health And VITAS Expansion Will Boost Future Prospects

Key Takeaways Successful integration of Covenant Health drives margin improvement and growth through positive revenue and EBITDA contributions. VITAS and Roto-Rooter initiatives signal promising revenue growth and improved earnings through strategic expansion and marketing strategies.
View narrative
US$663.67
FV
21.2% undervalued intrinsic discount
6.34%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
2 days ago author updated this narrative

Chemed Corporation Competitors

DaVita

NYSE:DVA

US$12.1b

CorVel

NasdaqGS:CRVL

US$5.7b

Option Care Health

NasdaqGS:OPCH

US$3.8b

Quest Diagnostics

NYSE:DGX

US$16.9b

Price History & Performance

Summary of share price highs, lows and changes for Chemed
Historical stock prices
Current Share PriceUS$523.16
52 Week HighUS$654.62
52 Week LowUS$516.91
Beta0.46
1 Month Change-5.37%
3 Month Change-10.12%
1 Year Change-11.78%
3 Year Change-0.41%
5 Year Change19.25%
Change since IPO4,524.62%

Recent News & Updates

With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case

Dec 18
With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case

Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?

Dec 03
Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?

Recent updates

With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case

Dec 18
With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case

Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?

Dec 03
Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 01
The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Oct 29
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Jul 19
Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Chemed declares $0.38 dividend

Nov 04

Shareholder Returns

CHEUS HealthcareUS Market
7D-4.4%-5.0%-3.5%
1Y-11.8%-11.4%22.1%

Return vs Industry: CHE matched the US Healthcare industry which returned -11.4% over the past year.

Return vs Market: CHE underperformed the US Market which returned 22.1% over the past year.

Price Volatility

Is CHE's price volatile compared to industry and market?
CHE volatility
CHE Average Weekly Movement4.2%
Healthcare Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: CHE has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CHE's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197015,087Kevin McNamarawww.chemed.com

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Chemed Corporation Fundamentals Summary

How do Chemed's earnings and revenue compare to its market cap?
CHE fundamental statistics
Market capUS$7.79b
Earnings (TTM)US$301.73m
Revenue (TTM)US$2.38b

25.9x

P/E Ratio

3.3x

P/S Ratio

Is CHE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CHE income statement (TTM)
RevenueUS$2.38b
Cost of RevenueUS$1.53b
Gross ProfitUS$847.80m
Other ExpensesUS$546.06m
EarningsUS$301.73m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)20.21
Gross Margin35.66%
Net Profit Margin12.69%
Debt/Equity Ratio0%

How did CHE perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

8%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 01:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Chemed Corporation is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Adam FeinsteinBarclays
Joanna Sylvia GajukBofA Global Research